HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Barton Grossman Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

1/2019Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
1/2019Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.
1/2019Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
1/2017Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.
11/2016Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design.
11/2016Phase 1b Trial to Evaluate Tissue Response to a Second Dose of Intravesical Recombinant Adenoviral Interferon α2b Formulated in Syn3 for Failures of Bacillus Calmette-Guerin (BCG) Therapy in Nonmuscle Invasive Bladder Cancer.
10/2016Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines.
10/2016Innovation in Bladder Cancer Immunotherapy.
4/2016The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer - A New Analysis.
4/2015Is Exam under Anesthesia Still Necessary for the Staging of Bladder Cancer in the Era of Modern Imaging?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Barton Grossman Research Topics

Disease

100Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 06/2002
62Neoplasms (Cancer)
01/2021 - 09/2002
17Carcinoma (Carcinomatosis)
01/2022 - 09/2003
15Non-Muscle Invasive Bladder Neoplasms
01/2021 - 03/2006
11Transitional Cell Carcinoma
01/2011 - 06/2003
5Neoplasm Metastasis (Metastasis)
11/2014 - 08/2003
4Aneuploidy (Aneuploid)
10/2008 - 09/2002
4Carcinoma in Situ
01/2008 - 06/2006
4Prostatic Neoplasms (Prostate Cancer)
12/2005 - 02/2004
3Disease Progression
11/2016 - 07/2007
3Lymphatic Metastasis
04/2015 - 12/2012
3Carcinogenesis
08/2010 - 01/2007
2Hernia (Hernias)
06/2014 - 08/2005
2Hematuria
07/2010 - 02/2008
2Stomach Neoplasms (Stomach Cancer)
06/2010 - 03/2010
2Margins of Excision
09/2009 - 01/2009
2Residual Neoplasm
09/2007 - 08/2003
1Obesity
01/2021
1Rare Diseases (Rare Disease)
08/2013
1Myocardial Infarction
02/2013
1Pneumonia (Pneumonitis)
02/2013
1Hydronephrosis
02/2013
1Thrombocytopenia (Thrombopenia)
02/2013
1Hearing Loss (Hearing Impairment)
02/2013
1Vomiting
02/2013
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
12/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2010

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
10/2014 - 09/2002
9Biomarkers (Surrogate Marker)IBA
01/2019 - 09/2002
85-aminolevulinic acid hexyl esterFDA Link
04/2016 - 07/2007
7Cisplatin (Platino)FDA LinkGeneric
01/2019 - 08/2003
6Doxorubicin (Adriamycin)FDA LinkGeneric
02/2013 - 08/2003
5nuclear matrix protein 22IBA
10/2011 - 02/2005
4InterferonsIBA
11/2016 - 12/2004
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2011 - 03/2003
4EnzymesIBA
03/2010 - 02/2003
4SmokeIBA
09/2008 - 12/2004
4DNA (Deoxyribonucleic Acid)IBA
07/2008 - 09/2002
4FenretinideIBA
01/2008 - 06/2002
4Benzo(a)pyreneIBA
03/2006 - 04/2003
4Epoxy Compounds (Epoxides)IBA
03/2006 - 04/2003
47,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA
03/2006 - 04/2003
3Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 - 09/2004
3Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2011 - 03/2003
3Celecoxib (Celebrex)FDA Link
10/2011 - 09/2002
3Methotrexate (Mexate)FDA LinkGeneric
09/2011 - 08/2003
3Vinblastine (Vinblastine Sulfate)FDA Link
09/2011 - 08/2003
3Phosphotransferases (Kinase)IBA
08/2010 - 09/2002
3LigandsIBA
08/2006 - 03/2003
3Messenger RNA (mRNA)IBA
10/2005 - 05/2004
2Indicators and Reagents (Reagents)IBA
11/2016 - 10/2016
2IfosfamideFDA LinkGeneric
02/2013 - 06/2009
2TOR Serine-Threonine KinasesIBA
08/2010 - 04/2010
2Pharmaceutical PreparationsIBA
08/2010 - 01/2007
2Tumor Biomarkers (Tumor Markers)IBA
06/2010 - 12/2005
2VitaminsIBA
11/2008 - 09/2002
2CarcinogensIBA
09/2008 - 01/2007
2Matrix Metalloproteinases (MMPs)IBA
05/2007 - 12/2006
2RetinoidsIBA
09/2006 - 01/2005
2Monoclonal AntibodiesIBA
02/2006 - 09/2002
2Nuclear Matrix-Associated ProteinsIBA
01/2006 - 02/2005
2ImmunosorbentsIBA
07/2005 - 02/2003
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2005 - 12/2004
2Connexin 26IBA
02/2004 - 03/2003
2ParaffinIBA
03/2003 - 09/2002
2Formaldehyde (Formol)FDA Link
03/2003 - 09/2002
1A 17 (A-17)IBA
11/2016
1CytokinesIBA
01/2016
1Interleukin-12 (IL 12)IBA
01/2016
1Genetic Markers (Genetic Marker)IBA
10/2014
1Cyclin EIBA
10/2014
1Photosensitizing Agents (Photosensitizers)IBA
10/2014
1Excipients (Suspending Agents)IBA
09/2013
1GemcitabineFDA Link
02/2013
1Anti-Bacterial Agents (Antibiotics)IBA
02/2013
1Anesthetics (Anesthetic Agents)IBA
02/2013
1AminesIBA
10/2012
1Urea (Carbamide)FDA LinkGeneric
11/2011
1Complement System Proteins (Complement)IBA
09/2011
1PlatinumIBA
09/2011
1EverolimusFDA Link
05/2011
1P-2 (P 2)IBA
10/2010

Therapy/Procedure

39Cystectomy
01/2019 - 06/2003
26Therapeutics
01/2022 - 06/2002
17Neoadjuvant Therapy
01/2019 - 08/2003
11Drug Therapy (Chemotherapy)
02/2013 - 06/2003
6Immunotherapy
01/2021 - 05/2003
6Chemoprevention
11/2008 - 09/2002
5Intravesical Administration
07/2007 - 06/2003
4Nephroureterectomy
11/2013 - 12/2006
3Aftercare (After-Treatment)
09/2013 - 06/2002
3Lymph Node Excision (Lymph Node Dissection)
12/2012 - 06/2003
2Anesthesia
04/2015 - 09/2007
2Urinary Diversion (Ileal Conduit)
06/2014 - 07/2010
2Combination Drug Therapy (Combination Chemotherapy)
09/2011 - 11/2006
2Adjuvant Chemotherapy
01/2009 - 01/2008
2Radiotherapy
03/2006 - 04/2004
1Conservative Treatment
04/2015
1Sutures (Suture)
06/2014
1Operative Time
07/2011